Tissue Banking research
Tissue Banking research

Tissue Banking Comprehensive Study by Type (Heart valves, Cornea, Bone, Skin, Brain & Spinal cord), Application (Therapeutics, Cosmetics, Research & development, Drug discovery, Others), Equipment (Cryopreservation Equipment, Thawing Equipment, Quality Control Equipment, Others), Tissue Type (Skin, Heart Valves, Corneas, Umbilical Cord) Players and Region - Global Market Outlook to 2024

Tissue Banking Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024 | CAGR: 7.49%  

May 2019 Edition 205 Pages 169 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Scope of the Study
Tissue banks are bio repositories used for storing umbilical cord tissues and blood, also contain different types of stem cells, each with the potential to treat various injuries and diseases. The method of storing these samples are known as Tissue banking. The use of automated tissue banking is playing a vital role in blood fractionation, DNA extraction, labelling, and capping techniques. Tissue banking is involved in for treating various debilitating conditions such as neurological diseases, cardiovascular, cancer, diabetes mellitus and other autoimmune diseases. These banks help in the storage of various types of tissue samples such as skin, bone, cornea, heart valves, umbilical cord, and human soft tissues. Further, regenerative medicines getting more recognition in healthcare centers & the emerging demand for tissue banking in bone marrow transplant are few factors driving the tissue banking market.

The market study is being classified by Type (Heart valves, Cornea, Bone, Skin and Brain & Spinal cord), by Application (Therapeutics, Cosmetics, Research & development, Drug discovery and Others) and major geographies with country level break-up. According to AMA, the Global Tissue Banking market is expected to see growth rate of 7.49%

BioCision, LLC (United States), Thermo Fisher, Inc. (United States), Tecan Trading AG (Switzerland), BioKryo GmbH (Germany), Brooks Automation (United States), Chernobyl Tissue Bank (United Kingdom), Cureline (United States), Eppendorf (India), IMA Pharma (India) and LifeLink Tissue Bank (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Tata Memorial Hospital Tissue Bank (India), The PXE International Blood and Tissue Bank (United States), Tissue Banks International (United States), TuBaFrost Group (United States), Wisconsin Tissue Bank (United States) and Teva Pharmaceutical Industries Ltd. (Israel).

The Global Tissue Banking market is highly fragmented with the presence of several vendors. The global vendors are dominating the market, however, most of the product offerings of these companies are almost similar. To increase product sales, players are differentiating their products through automation, value-added services, and collaborations and partnerships with research and academic institutions. The companies are offering cost-effective consumables and are likely to succeed as tissue banks are concentrating on reducing the overall preservation cost of tissue banking

Segment Analysis
AdvanceMarketAnalytics has segmented the market of Global Tissue Banking market by Type, Application and Region.

On the basis of geography, the market of Tissue Banking has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2018. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement. If we see Market by Equipment, the sub-segment i.e. Cryopreservation Equipment will boost the Tissue Banking market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Tissue Type, the sub-segment i.e. Skin will boost the Tissue Banking market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Rising Geriatric Population & Biobanks
  • High Prevalence of Chronic Diseases and Need For Umbilical Cord Preservation
  • Increasing Awareness for Tissue Donation
  • Growing Adoption of Advanced Cosmetic Surgeries

Market Trend
  • Surge in Government Initiatives to Promote Better Healthcare Facilities
  • Technological advancements such as Ultra-low freezer and Automated Freezer having storage Capacity of 1 billion Samples

Restraints
  • Stringent Regulatory Requirements May Hamper the Market Growth

Opportunities
  • Automation in Tissue banking
  • Increasing R &D Investment in Healthcare Sector

Challenges
  • Limited standardization in sample collection & Number of Tissue Donors


Market Leaders and their expansionary development strategies
January 2018, C Vijaya Baskar (Health Minister of India) launched the first tissue bank at the Government Kilpauk Medical College Hospital in the Southern region, thereby powering the development of tissue banking market.
In July 2018, PHC Corporation introduced the new -85°C ultra-low temperature freezer VIP ECO series 1 using natural refrigerants 2 and new inverter compressors for the market in Japan, designed specifically for pharmaceutical companies and research and medical institutions. and This product series comprises of models that are specially designed for pharmaceutical companies, research, and medical institutions.


Key Target Audience
Tissue Banking Storage Manufacturers, Government & Regulatory Bodies, Industry Associations, Potential Investors, Downstream Vendors and Biobanking Regulators

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Heart valves
  • Cornea
  • Bone
  • Skin
  • Brain & Spinal cord
By Application
  • Therapeutics
  • Cosmetics
  • Research & development
  • Drug discovery
  • Others
By Equipment
  • Cryopreservation Equipment
  • Thawing Equipment
  • Quality Control Equipment
  • Others

By Tissue Type
  • Skin
  • Heart Valves
  • Corneas
  • Umbilical Cord

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Geriatric Population & Biobanks
      • 3.2.2. High Prevalence of Chronic Diseases and Need For Umbilical Cord Preservation
      • 3.2.3. Increasing Awareness for Tissue Donation
      • 3.2.4. Growing Adoption of Advanced Cosmetic Surgeries
    • 3.3. Market Challenges
      • 3.3.1. Limited standardization in sample collection & Number of Tissue Donors
    • 3.4. Market Trends
      • 3.4.1. Surge in Government Initiatives to Promote Better Healthcare Facilities
      • 3.4.2. Technological advancements such as Ultra-low freezer and Automated Freezer having storage Capacity of 1 billion Samples
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Tissue Banking, by Type, Application, Equipment, Tissue Type and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Tissue Banking (Value)
      • 5.2.1. Global Tissue Banking by: Type (Value)
        • 5.2.1.1. Heart valves
        • 5.2.1.2. Cornea
        • 5.2.1.3. Bone
        • 5.2.1.4. Skin
        • 5.2.1.5. Brain & Spinal cord
      • 5.2.2. Global Tissue Banking by: Application (Value)
        • 5.2.2.1. Therapeutics
        • 5.2.2.2. Cosmetics
        • 5.2.2.3. Research & development
        • 5.2.2.4. Drug discovery
        • 5.2.2.5. Others
      • 5.2.3. Global Tissue Banking by: Equipment (Value)
        • 5.2.3.1. Cryopreservation Equipment
        • 5.2.3.2. Thawing Equipment
        • 5.2.3.3. Quality Control Equipment
        • 5.2.3.4. Others
      • 5.2.4. Global Tissue Banking by: Tissue Type (Value)
        • 5.2.4.1. Skin
        • 5.2.4.2. Heart Valves
        • 5.2.4.3. Corneas
        • 5.2.4.4. Umbilical Cord
      • 5.2.5. Global Tissue Banking Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Tissue Banking: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. BioCision, LLC (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Thermo Fisher, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Tecan Trading AG (Switzerland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. BioKryo GmbH (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Brooks Automation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Chernobyl Tissue Bank (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Cureline (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Eppendorf (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. IMA Pharma (India)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. LifeLink Tissue Bank (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Tissue Banking Sale, by Type, Application, Equipment, Tissue Type and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Tissue Banking (Value)
      • 7.2.1. Global Tissue Banking by: Type (Value)
        • 7.2.1.1. Heart valves
        • 7.2.1.2. Cornea
        • 7.2.1.3. Bone
        • 7.2.1.4. Skin
        • 7.2.1.5. Brain & Spinal cord
      • 7.2.2. Global Tissue Banking by: Application (Value)
        • 7.2.2.1. Therapeutics
        • 7.2.2.2. Cosmetics
        • 7.2.2.3. Research & development
        • 7.2.2.4. Drug discovery
        • 7.2.2.5. Others
      • 7.2.3. Global Tissue Banking by: Equipment (Value)
        • 7.2.3.1. Cryopreservation Equipment
        • 7.2.3.2. Thawing Equipment
        • 7.2.3.3. Quality Control Equipment
        • 7.2.3.4. Others
      • 7.2.4. Global Tissue Banking by: Tissue Type (Value)
        • 7.2.4.1. Skin
        • 7.2.4.2. Heart Valves
        • 7.2.4.3. Corneas
        • 7.2.4.4. Umbilical Cord
      • 7.2.5. Global Tissue Banking Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Tissue Banking: by Type(USD Million)
  • Table 2. Tissue Banking Heart valves , by Region USD Million (2013-2018)
  • Table 3. Tissue Banking Cornea , by Region USD Million (2013-2018)
  • Table 4. Tissue Banking Bone , by Region USD Million (2013-2018)
  • Table 5. Tissue Banking Skin , by Region USD Million (2013-2018)
  • Table 6. Tissue Banking Brain & Spinal cord , by Region USD Million (2013-2018)
  • Table 7. Tissue Banking: by Application(USD Million)
  • Table 8. Tissue Banking Therapeutics , by Region USD Million (2013-2018)
  • Table 9. Tissue Banking Cosmetics , by Region USD Million (2013-2018)
  • Table 10. Tissue Banking Research & development , by Region USD Million (2013-2018)
  • Table 11. Tissue Banking Drug discovery , by Region USD Million (2013-2018)
  • Table 12. Tissue Banking Others , by Region USD Million (2013-2018)
  • Table 13. Tissue Banking: by Equipment(USD Million)
  • Table 14. Tissue Banking Cryopreservation Equipment , by Region USD Million (2013-2018)
  • Table 15. Tissue Banking Thawing Equipment , by Region USD Million (2013-2018)
  • Table 16. Tissue Banking Quality Control Equipment , by Region USD Million (2013-2018)
  • Table 17. Tissue Banking Others , by Region USD Million (2013-2018)
  • Table 18. Tissue Banking: by Tissue Type(USD Million)
  • Table 19. Tissue Banking Skin , by Region USD Million (2013-2018)
  • Table 20. Tissue Banking Heart Valves , by Region USD Million (2013-2018)
  • Table 21. Tissue Banking Corneas , by Region USD Million (2013-2018)
  • Table 22. Tissue Banking Umbilical Cord , by Region USD Million (2013-2018)
  • Table 23. South America Tissue Banking, by Country USD Million (2013-2018)
  • Table 24. South America Tissue Banking, by Type USD Million (2013-2018)
  • Table 25. South America Tissue Banking, by Application USD Million (2013-2018)
  • Table 26. South America Tissue Banking, by Equipment USD Million (2013-2018)
  • Table 27. South America Tissue Banking, by Tissue Type USD Million (2013-2018)
  • Table 28. Brazil Tissue Banking, by Type USD Million (2013-2018)
  • Table 29. Brazil Tissue Banking, by Application USD Million (2013-2018)
  • Table 30. Brazil Tissue Banking, by Equipment USD Million (2013-2018)
  • Table 31. Brazil Tissue Banking, by Tissue Type USD Million (2013-2018)
  • Table 32. Argentina Tissue Banking, by Type USD Million (2013-2018)
  • Table 33. Argentina Tissue Banking, by Application USD Million (2013-2018)
  • Table 34. Argentina Tissue Banking, by Equipment USD Million (2013-2018)
  • Table 35. Argentina Tissue Banking, by Tissue Type USD Million (2013-2018)
  • Table 36. Rest of South America Tissue Banking, by Type USD Million (2013-2018)
  • Table 37. Rest of South America Tissue Banking, by Application USD Million (2013-2018)
  • Table 38. Rest of South America Tissue Banking, by Equipment USD Million (2013-2018)
  • Table 39. Rest of South America Tissue Banking, by Tissue Type USD Million (2013-2018)
  • Table 40. Asia Pacific Tissue Banking, by Country USD Million (2013-2018)
  • Table 41. Asia Pacific Tissue Banking, by Type USD Million (2013-2018)
  • Table 42. Asia Pacific Tissue Banking, by Application USD Million (2013-2018)
  • Table 43. Asia Pacific Tissue Banking, by Equipment USD Million (2013-2018)
  • Table 44. Asia Pacific Tissue Banking, by Tissue Type USD Million (2013-2018)
  • Table 45. China Tissue Banking, by Type USD Million (2013-2018)
  • Table 46. China Tissue Banking, by Application USD Million (2013-2018)
  • Table 47. China Tissue Banking, by Equipment USD Million (2013-2018)
  • Table 48. China Tissue Banking, by Tissue Type USD Million (2013-2018)
  • Table 49. Japan Tissue Banking, by Type USD Million (2013-2018)
  • Table 50. Japan Tissue Banking, by Application USD Million (2013-2018)
  • Table 51. Japan Tissue Banking, by Equipment USD Million (2013-2018)
  • Table 52. Japan Tissue Banking, by Tissue Type USD Million (2013-2018)
  • Table 53. India Tissue Banking, by Type USD Million (2013-2018)
  • Table 54. India Tissue Banking, by Application USD Million (2013-2018)
  • Table 55. India Tissue Banking, by Equipment USD Million (2013-2018)
  • Table 56. India Tissue Banking, by Tissue Type USD Million (2013-2018)
  • Table 57. South Korea Tissue Banking, by Type USD Million (2013-2018)
  • Table 58. South Korea Tissue Banking, by Application USD Million (2013-2018)
  • Table 59. South Korea Tissue Banking, by Equipment USD Million (2013-2018)
  • Table 60. South Korea Tissue Banking, by Tissue Type USD Million (2013-2018)
  • Table 61. Taiwan Tissue Banking, by Type USD Million (2013-2018)
  • Table 62. Taiwan Tissue Banking, by Application USD Million (2013-2018)
  • Table 63. Taiwan Tissue Banking, by Equipment USD Million (2013-2018)
  • Table 64. Taiwan Tissue Banking, by Tissue Type USD Million (2013-2018)
  • Table 65. Australia Tissue Banking, by Type USD Million (2013-2018)
  • Table 66. Australia Tissue Banking, by Application USD Million (2013-2018)
  • Table 67. Australia Tissue Banking, by Equipment USD Million (2013-2018)
  • Table 68. Australia Tissue Banking, by Tissue Type USD Million (2013-2018)
  • Table 69. Rest of Asia-Pacific Tissue Banking, by Type USD Million (2013-2018)
  • Table 70. Rest of Asia-Pacific Tissue Banking, by Application USD Million (2013-2018)
  • Table 71. Rest of Asia-Pacific Tissue Banking, by Equipment USD Million (2013-2018)
  • Table 72. Rest of Asia-Pacific Tissue Banking, by Tissue Type USD Million (2013-2018)
  • Table 73. Europe Tissue Banking, by Country USD Million (2013-2018)
  • Table 74. Europe Tissue Banking, by Type USD Million (2013-2018)
  • Table 75. Europe Tissue Banking, by Application USD Million (2013-2018)
  • Table 76. Europe Tissue Banking, by Equipment USD Million (2013-2018)
  • Table 77. Europe Tissue Banking, by Tissue Type USD Million (2013-2018)
  • Table 78. Germany Tissue Banking, by Type USD Million (2013-2018)
  • Table 79. Germany Tissue Banking, by Application USD Million (2013-2018)
  • Table 80. Germany Tissue Banking, by Equipment USD Million (2013-2018)
  • Table 81. Germany Tissue Banking, by Tissue Type USD Million (2013-2018)
  • Table 82. France Tissue Banking, by Type USD Million (2013-2018)
  • Table 83. France Tissue Banking, by Application USD Million (2013-2018)
  • Table 84. France Tissue Banking, by Equipment USD Million (2013-2018)
  • Table 85. France Tissue Banking, by Tissue Type USD Million (2013-2018)
  • Table 86. Italy Tissue Banking, by Type USD Million (2013-2018)
  • Table 87. Italy Tissue Banking, by Application USD Million (2013-2018)
  • Table 88. Italy Tissue Banking, by Equipment USD Million (2013-2018)
  • Table 89. Italy Tissue Banking, by Tissue Type USD Million (2013-2018)
  • Table 90. United Kingdom Tissue Banking, by Type USD Million (2013-2018)
  • Table 91. United Kingdom Tissue Banking, by Application USD Million (2013-2018)
  • Table 92. United Kingdom Tissue Banking, by Equipment USD Million (2013-2018)
  • Table 93. United Kingdom Tissue Banking, by Tissue Type USD Million (2013-2018)
  • Table 94. Netherlands Tissue Banking, by Type USD Million (2013-2018)
  • Table 95. Netherlands Tissue Banking, by Application USD Million (2013-2018)
  • Table 96. Netherlands Tissue Banking, by Equipment USD Million (2013-2018)
  • Table 97. Netherlands Tissue Banking, by Tissue Type USD Million (2013-2018)
  • Table 98. Rest of Europe Tissue Banking, by Type USD Million (2013-2018)
  • Table 99. Rest of Europe Tissue Banking, by Application USD Million (2013-2018)
  • Table 100. Rest of Europe Tissue Banking, by Equipment USD Million (2013-2018)
  • Table 101. Rest of Europe Tissue Banking, by Tissue Type USD Million (2013-2018)
  • Table 102. MEA Tissue Banking, by Country USD Million (2013-2018)
  • Table 103. MEA Tissue Banking, by Type USD Million (2013-2018)
  • Table 104. MEA Tissue Banking, by Application USD Million (2013-2018)
  • Table 105. MEA Tissue Banking, by Equipment USD Million (2013-2018)
  • Table 106. MEA Tissue Banking, by Tissue Type USD Million (2013-2018)
  • Table 107. Middle East Tissue Banking, by Type USD Million (2013-2018)
  • Table 108. Middle East Tissue Banking, by Application USD Million (2013-2018)
  • Table 109. Middle East Tissue Banking, by Equipment USD Million (2013-2018)
  • Table 110. Middle East Tissue Banking, by Tissue Type USD Million (2013-2018)
  • Table 111. Africa Tissue Banking, by Type USD Million (2013-2018)
  • Table 112. Africa Tissue Banking, by Application USD Million (2013-2018)
  • Table 113. Africa Tissue Banking, by Equipment USD Million (2013-2018)
  • Table 114. Africa Tissue Banking, by Tissue Type USD Million (2013-2018)
  • Table 115. North America Tissue Banking, by Country USD Million (2013-2018)
  • Table 116. North America Tissue Banking, by Type USD Million (2013-2018)
  • Table 117. North America Tissue Banking, by Application USD Million (2013-2018)
  • Table 118. North America Tissue Banking, by Equipment USD Million (2013-2018)
  • Table 119. North America Tissue Banking, by Tissue Type USD Million (2013-2018)
  • Table 120. United States Tissue Banking, by Type USD Million (2013-2018)
  • Table 121. United States Tissue Banking, by Application USD Million (2013-2018)
  • Table 122. United States Tissue Banking, by Equipment USD Million (2013-2018)
  • Table 123. United States Tissue Banking, by Tissue Type USD Million (2013-2018)
  • Table 124. Canada Tissue Banking, by Type USD Million (2013-2018)
  • Table 125. Canada Tissue Banking, by Application USD Million (2013-2018)
  • Table 126. Canada Tissue Banking, by Equipment USD Million (2013-2018)
  • Table 127. Canada Tissue Banking, by Tissue Type USD Million (2013-2018)
  • Table 128. Mexico Tissue Banking, by Type USD Million (2013-2018)
  • Table 129. Mexico Tissue Banking, by Application USD Million (2013-2018)
  • Table 130. Mexico Tissue Banking, by Equipment USD Million (2013-2018)
  • Table 131. Mexico Tissue Banking, by Tissue Type USD Million (2013-2018)
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Tissue Banking: by Type(USD Million)
  • Table 143. Tissue Banking Heart valves , by Region USD Million (2019-2024)
  • Table 144. Tissue Banking Cornea , by Region USD Million (2019-2024)
  • Table 145. Tissue Banking Bone , by Region USD Million (2019-2024)
  • Table 146. Tissue Banking Skin , by Region USD Million (2019-2024)
  • Table 147. Tissue Banking Brain & Spinal cord , by Region USD Million (2019-2024)
  • Table 148. Tissue Banking: by Application(USD Million)
  • Table 149. Tissue Banking Therapeutics , by Region USD Million (2019-2024)
  • Table 150. Tissue Banking Cosmetics , by Region USD Million (2019-2024)
  • Table 151. Tissue Banking Research & development , by Region USD Million (2019-2024)
  • Table 152. Tissue Banking Drug discovery , by Region USD Million (2019-2024)
  • Table 153. Tissue Banking Others , by Region USD Million (2019-2024)
  • Table 154. Tissue Banking: by Equipment(USD Million)
  • Table 155. Tissue Banking Cryopreservation Equipment , by Region USD Million (2019-2024)
  • Table 156. Tissue Banking Thawing Equipment , by Region USD Million (2019-2024)
  • Table 157. Tissue Banking Quality Control Equipment , by Region USD Million (2019-2024)
  • Table 158. Tissue Banking Others , by Region USD Million (2019-2024)
  • Table 159. Tissue Banking: by Tissue Type(USD Million)
  • Table 160. Tissue Banking Skin , by Region USD Million (2019-2024)
  • Table 161. Tissue Banking Heart Valves , by Region USD Million (2019-2024)
  • Table 162. Tissue Banking Corneas , by Region USD Million (2019-2024)
  • Table 163. Tissue Banking Umbilical Cord , by Region USD Million (2019-2024)
  • Table 164. South America Tissue Banking, by Country USD Million (2019-2024)
  • Table 165. South America Tissue Banking, by Type USD Million (2019-2024)
  • Table 166. South America Tissue Banking, by Application USD Million (2019-2024)
  • Table 167. South America Tissue Banking, by Equipment USD Million (2019-2024)
  • Table 168. South America Tissue Banking, by Tissue Type USD Million (2019-2024)
  • Table 169. Brazil Tissue Banking, by Type USD Million (2019-2024)
  • Table 170. Brazil Tissue Banking, by Application USD Million (2019-2024)
  • Table 171. Brazil Tissue Banking, by Equipment USD Million (2019-2024)
  • Table 172. Brazil Tissue Banking, by Tissue Type USD Million (2019-2024)
  • Table 173. Argentina Tissue Banking, by Type USD Million (2019-2024)
  • Table 174. Argentina Tissue Banking, by Application USD Million (2019-2024)
  • Table 175. Argentina Tissue Banking, by Equipment USD Million (2019-2024)
  • Table 176. Argentina Tissue Banking, by Tissue Type USD Million (2019-2024)
  • Table 177. Rest of South America Tissue Banking, by Type USD Million (2019-2024)
  • Table 178. Rest of South America Tissue Banking, by Application USD Million (2019-2024)
  • Table 179. Rest of South America Tissue Banking, by Equipment USD Million (2019-2024)
  • Table 180. Rest of South America Tissue Banking, by Tissue Type USD Million (2019-2024)
  • Table 181. Asia Pacific Tissue Banking, by Country USD Million (2019-2024)
  • Table 182. Asia Pacific Tissue Banking, by Type USD Million (2019-2024)
  • Table 183. Asia Pacific Tissue Banking, by Application USD Million (2019-2024)
  • Table 184. Asia Pacific Tissue Banking, by Equipment USD Million (2019-2024)
  • Table 185. Asia Pacific Tissue Banking, by Tissue Type USD Million (2019-2024)
  • Table 186. China Tissue Banking, by Type USD Million (2019-2024)
  • Table 187. China Tissue Banking, by Application USD Million (2019-2024)
  • Table 188. China Tissue Banking, by Equipment USD Million (2019-2024)
  • Table 189. China Tissue Banking, by Tissue Type USD Million (2019-2024)
  • Table 190. Japan Tissue Banking, by Type USD Million (2019-2024)
  • Table 191. Japan Tissue Banking, by Application USD Million (2019-2024)
  • Table 192. Japan Tissue Banking, by Equipment USD Million (2019-2024)
  • Table 193. Japan Tissue Banking, by Tissue Type USD Million (2019-2024)
  • Table 194. India Tissue Banking, by Type USD Million (2019-2024)
  • Table 195. India Tissue Banking, by Application USD Million (2019-2024)
  • Table 196. India Tissue Banking, by Equipment USD Million (2019-2024)
  • Table 197. India Tissue Banking, by Tissue Type USD Million (2019-2024)
  • Table 198. South Korea Tissue Banking, by Type USD Million (2019-2024)
  • Table 199. South Korea Tissue Banking, by Application USD Million (2019-2024)
  • Table 200. South Korea Tissue Banking, by Equipment USD Million (2019-2024)
  • Table 201. South Korea Tissue Banking, by Tissue Type USD Million (2019-2024)
  • Table 202. Taiwan Tissue Banking, by Type USD Million (2019-2024)
  • Table 203. Taiwan Tissue Banking, by Application USD Million (2019-2024)
  • Table 204. Taiwan Tissue Banking, by Equipment USD Million (2019-2024)
  • Table 205. Taiwan Tissue Banking, by Tissue Type USD Million (2019-2024)
  • Table 206. Australia Tissue Banking, by Type USD Million (2019-2024)
  • Table 207. Australia Tissue Banking, by Application USD Million (2019-2024)
  • Table 208. Australia Tissue Banking, by Equipment USD Million (2019-2024)
  • Table 209. Australia Tissue Banking, by Tissue Type USD Million (2019-2024)
  • Table 210. Rest of Asia-Pacific Tissue Banking, by Type USD Million (2019-2024)
  • Table 211. Rest of Asia-Pacific Tissue Banking, by Application USD Million (2019-2024)
  • Table 212. Rest of Asia-Pacific Tissue Banking, by Equipment USD Million (2019-2024)
  • Table 213. Rest of Asia-Pacific Tissue Banking, by Tissue Type USD Million (2019-2024)
  • Table 214. Europe Tissue Banking, by Country USD Million (2019-2024)
  • Table 215. Europe Tissue Banking, by Type USD Million (2019-2024)
  • Table 216. Europe Tissue Banking, by Application USD Million (2019-2024)
  • Table 217. Europe Tissue Banking, by Equipment USD Million (2019-2024)
  • Table 218. Europe Tissue Banking, by Tissue Type USD Million (2019-2024)
  • Table 219. Germany Tissue Banking, by Type USD Million (2019-2024)
  • Table 220. Germany Tissue Banking, by Application USD Million (2019-2024)
  • Table 221. Germany Tissue Banking, by Equipment USD Million (2019-2024)
  • Table 222. Germany Tissue Banking, by Tissue Type USD Million (2019-2024)
  • Table 223. France Tissue Banking, by Type USD Million (2019-2024)
  • Table 224. France Tissue Banking, by Application USD Million (2019-2024)
  • Table 225. France Tissue Banking, by Equipment USD Million (2019-2024)
  • Table 226. France Tissue Banking, by Tissue Type USD Million (2019-2024)
  • Table 227. Italy Tissue Banking, by Type USD Million (2019-2024)
  • Table 228. Italy Tissue Banking, by Application USD Million (2019-2024)
  • Table 229. Italy Tissue Banking, by Equipment USD Million (2019-2024)
  • Table 230. Italy Tissue Banking, by Tissue Type USD Million (2019-2024)
  • Table 231. United Kingdom Tissue Banking, by Type USD Million (2019-2024)
  • Table 232. United Kingdom Tissue Banking, by Application USD Million (2019-2024)
  • Table 233. United Kingdom Tissue Banking, by Equipment USD Million (2019-2024)
  • Table 234. United Kingdom Tissue Banking, by Tissue Type USD Million (2019-2024)
  • Table 235. Netherlands Tissue Banking, by Type USD Million (2019-2024)
  • Table 236. Netherlands Tissue Banking, by Application USD Million (2019-2024)
  • Table 237. Netherlands Tissue Banking, by Equipment USD Million (2019-2024)
  • Table 238. Netherlands Tissue Banking, by Tissue Type USD Million (2019-2024)
  • Table 239. Rest of Europe Tissue Banking, by Type USD Million (2019-2024)
  • Table 240. Rest of Europe Tissue Banking, by Application USD Million (2019-2024)
  • Table 241. Rest of Europe Tissue Banking, by Equipment USD Million (2019-2024)
  • Table 242. Rest of Europe Tissue Banking, by Tissue Type USD Million (2019-2024)
  • Table 243. MEA Tissue Banking, by Country USD Million (2019-2024)
  • Table 244. MEA Tissue Banking, by Type USD Million (2019-2024)
  • Table 245. MEA Tissue Banking, by Application USD Million (2019-2024)
  • Table 246. MEA Tissue Banking, by Equipment USD Million (2019-2024)
  • Table 247. MEA Tissue Banking, by Tissue Type USD Million (2019-2024)
  • Table 248. Middle East Tissue Banking, by Type USD Million (2019-2024)
  • Table 249. Middle East Tissue Banking, by Application USD Million (2019-2024)
  • Table 250. Middle East Tissue Banking, by Equipment USD Million (2019-2024)
  • Table 251. Middle East Tissue Banking, by Tissue Type USD Million (2019-2024)
  • Table 252. Africa Tissue Banking, by Type USD Million (2019-2024)
  • Table 253. Africa Tissue Banking, by Application USD Million (2019-2024)
  • Table 254. Africa Tissue Banking, by Equipment USD Million (2019-2024)
  • Table 255. Africa Tissue Banking, by Tissue Type USD Million (2019-2024)
  • Table 256. North America Tissue Banking, by Country USD Million (2019-2024)
  • Table 257. North America Tissue Banking, by Type USD Million (2019-2024)
  • Table 258. North America Tissue Banking, by Application USD Million (2019-2024)
  • Table 259. North America Tissue Banking, by Equipment USD Million (2019-2024)
  • Table 260. North America Tissue Banking, by Tissue Type USD Million (2019-2024)
  • Table 261. United States Tissue Banking, by Type USD Million (2019-2024)
  • Table 262. United States Tissue Banking, by Application USD Million (2019-2024)
  • Table 263. United States Tissue Banking, by Equipment USD Million (2019-2024)
  • Table 264. United States Tissue Banking, by Tissue Type USD Million (2019-2024)
  • Table 265. Canada Tissue Banking, by Type USD Million (2019-2024)
  • Table 266. Canada Tissue Banking, by Application USD Million (2019-2024)
  • Table 267. Canada Tissue Banking, by Equipment USD Million (2019-2024)
  • Table 268. Canada Tissue Banking, by Tissue Type USD Million (2019-2024)
  • Table 269. Mexico Tissue Banking, by Type USD Million (2019-2024)
  • Table 270. Mexico Tissue Banking, by Application USD Million (2019-2024)
  • Table 271. Mexico Tissue Banking, by Equipment USD Million (2019-2024)
  • Table 272. Mexico Tissue Banking, by Tissue Type USD Million (2019-2024)
  • Table 273. Research Programs/Design for This Report
  • Table 274. Key Data Information from Secondary Sources
  • Table 275. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Tissue Banking: by Type USD Million (2013-2018)
  • Figure 5. Global Tissue Banking: by Application USD Million (2013-2018)
  • Figure 6. Global Tissue Banking: by Equipment USD Million (2013-2018)
  • Figure 7. Global Tissue Banking: by Tissue Type USD Million (2013-2018)
  • Figure 8. South America Tissue Banking Share (%), by Country
  • Figure 9. Asia Pacific Tissue Banking Share (%), by Country
  • Figure 10. Europe Tissue Banking Share (%), by Country
  • Figure 11. MEA Tissue Banking Share (%), by Country
  • Figure 12. North America Tissue Banking Share (%), by Country
  • Figure 13. Global Tissue Banking share by Players 2018 (%)
  • Figure 14. Global Tissue Banking share by Players (Top 3) 2018(%)
  • Figure 15. Global Tissue Banking share by Players (Top 5) 2018(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. BioCision, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 18. BioCision, LLC (United States) Revenue: by Geography 2018
  • Figure 19. Thermo Fisher, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Thermo Fisher, Inc. (United States) Revenue: by Geography 2018
  • Figure 21. Tecan Trading AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 22. Tecan Trading AG (Switzerland) Revenue: by Geography 2018
  • Figure 23. BioKryo GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 24. BioKryo GmbH (Germany) Revenue: by Geography 2018
  • Figure 25. Brooks Automation (United States) Revenue, Net Income and Gross profit
  • Figure 26. Brooks Automation (United States) Revenue: by Geography 2018
  • Figure 27. Chernobyl Tissue Bank (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 28. Chernobyl Tissue Bank (United Kingdom) Revenue: by Geography 2018
  • Figure 29. Cureline (United States) Revenue, Net Income and Gross profit
  • Figure 30. Cureline (United States) Revenue: by Geography 2018
  • Figure 31. Eppendorf (India) Revenue, Net Income and Gross profit
  • Figure 32. Eppendorf (India) Revenue: by Geography 2018
  • Figure 33. IMA Pharma (India) Revenue, Net Income and Gross profit
  • Figure 34. IMA Pharma (India) Revenue: by Geography 2018
  • Figure 35. LifeLink Tissue Bank (United States) Revenue, Net Income and Gross profit
  • Figure 36. LifeLink Tissue Bank (United States) Revenue: by Geography 2018
  • Figure 37. Global Tissue Banking: by Type USD Million (2019-2024)
  • Figure 38. Global Tissue Banking: by Application USD Million (2019-2024)
  • Figure 39. Global Tissue Banking: by Equipment USD Million (2019-2024)
  • Figure 40. Global Tissue Banking: by Tissue Type USD Million (2019-2024)
  • Figure 41. South America Tissue Banking Share (%), by Country
  • Figure 42. Asia Pacific Tissue Banking Share (%), by Country
  • Figure 43. Europe Tissue Banking Share (%), by Country
  • Figure 44. MEA Tissue Banking Share (%), by Country
  • Figure 45. North America Tissue Banking Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • BioCision, LLC (United States)
  • Thermo Fisher, Inc. (United States)
  • Tecan Trading AG (Switzerland)
  • BioKryo GmbH (Germany)
  • Brooks Automation (United States)
  • Chernobyl Tissue Bank (United Kingdom)
  • Cureline (United States)
  • Eppendorf (India)
  • IMA Pharma (India)
  • LifeLink Tissue Bank (United States)
Additional players considered in the study are as follows:
Tata Memorial Hospital Tissue Bank (India) , The PXE International Blood and Tissue Bank (United States) , Tissue Banks International (United States) , TuBaFrost Group (United States) , Wisconsin Tissue Bank (United States) , Teva Pharmaceutical Industries Ltd. (Israel)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation